Avenzo Therapeutics Recruiting Site

Nashville, Tennessee 37203

2 studies enrolling now · 2 studies all time

What they study most

HR+, HER2-, Advanced Breast Cancer, HR+/HER2- Breast Cancer, Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer, Urothelial Cancer

Studies at this site

• ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors — Recruiting now
• BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) — Recruiting now